Article
Generic drugmakers to sell Pfizer's Paxlovid for $25 or less in low-income countries
Rating:
0.0
Views:
41
Likes:
1
Library:
1
Several generic drugmakers that will produce versions of Pfizer's COVID-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for $25 a course or less, the Clinton Health Access Initiative (CHAI) said on Thursday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value